On Tuesday, I shared a piece here about companies that are making adjustments now, in anticipation of new rules or legislation that could limit such actions later (see, "Grabbing cookies while the lid is off the jar," 11/17/09). As one example, I focused on pharmaceutical companies that were raising prices on prescription drugs... ahead of anticipated health care reform.
This morning, the New York Times ran a story indicating that a group of lawmakers have noticed what's going on (due to widespread media reports), and are launching an inquiry. (See the story here.)
Mike Anderson
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment